Gonzalo Castillo-Rojas

Dr. Gonzalo Castillo-Rojas


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2017 in Frontiers in Medicine
Verified
Journal Article
Open access
CRClaudia I. Rivas-Ortiz
Claudia I. Rivas-Ortiz
YLYolanda Lopez-Vidal
Yolanda Lopez-Vidal
RARene Arredondo-Hernandez
Rene Arredondo-Hernandez
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
Gastric cancer is a world health problem, and depicts the fourth leading mortality cause from malignancy in Mexico. Causation of gastric cancer is not only due to the combined effects of environmental factors and genetic variants. Recent molecular studies have transgressed a number of genes involved in gastric carcinogenesis. The aim of this review is to understand the recent basics of gene expression in the development of the process of gastric carcinogenesis. Genetic variants, polymorphisms, DNA methylation, and genes involved in mediating inflammation, have been associated with the development of gastric carcinogenesis. Recently, these genes (IL-10, Il-17, MUC1, β-catenin, CDX1, SMAD4, SERPINE1, HIF-1α, GSK3β, CDH17, MMP7, RUNX3, RASSF1A, TFF1, HAI-2 and COX-2) have been studied in association with oncogenic activation or inactivation of tumor suppressor genes. All these mechanisms have been investigated to elucidate the process of gastric carcinogenesis, as well as their potential use as biomarkers and/or molecular targets to treatment of disease.

15 July 2008 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
MCMarco A Cerbón
Marco A Cerbón
YVYolanda López- Vidal
Yolanda López- Vidal
Recent studies showed that Helicobacter pylori existed in the New World prior to the arrival of Columbus. The purpose of the present study was to detect the presence of Helicobacter pylori in pre-Columbian mummies from Northern Mexico.

21 November 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
YVYolanda López- Vidal
Yolanda López- Vidal
PSPonce-De-León Sergio
Ponce-De-León Sergio
HEHugo Esquivel-Solís
Hugo Esquivel-Solís
AIAmieva-Fernández Rosa Isabel
Amieva-Fernández Rosa Isabel
BRBarreto-Zúñiga Rafael
Barreto-Zúñiga Rafael
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
Although the association between H. pylori and gastric cancer has been well described, the alterations studies are scarce in the humoral immune response in specific anatomical areas of stomach and during the stages of gastric cancer. The aim in this study was to determine the influence of humoral immune responses against H. pylori infection on gastric carcinoma. We selected 16 gastric cancer cases and approximately one matched control per case at the National Institute of Medical Sciences and Nutrition Salvador Zubirán (INCMNSZ); all the cases met the inclusion criteria for the study. We obtained three biopsies from each patient and from each of the predetermined regions of the stomach: antrum, angular portion, corpus, and fundus. From the patients with gastric cancer, additional biopsy specimens were obtained from tumor mid-lesion and tumor margin, and additional specimens were collected at least 2 and 5 cm from the tumor margin. We compared IgA levels against H. pylori in each area of stomach between cases and controls as well as between early and advanced stages of gastric cancer. IgA values were strikingly elevated in cancer cases compared with control subjects; a value that was even higher in the distant periphery of tumor but was remarkably decreased toward the carcinoma lesion. The advanced stages of gastric cancer demonstrated the relapse of the humoral immune response in the mid-lesion region of the tumor compared with the tumor margins and adjacent non-tumor tissue. Gastric cancer is characterized by progressive accumulation of a concentrated, specific IgA response against H. pylori, beginning with an abnormal increase in the entire stomach but particularly in the adjacent non-tumor tissue. Thus, it is possible that this strong immune response also participates in some degree in the damage and in the development of gastric cancer to some extent.

13 May 2011 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
FAFernando Antonio-Rincón
Fernando Antonio-Rincón
YVYolanda López- Vidal
Yolanda López- Vidal
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
ELEduardo Lazcano-Ponce
Eduardo Lazcano-Ponce
SPSergio Ponce-De-León
Sergio Ponce-De-León
GAGermán Rubén Aguilar-Gutiérrez
Germán Rubén Aguilar-Gutiérrez
Background: Helicobacter pylori is associated with chronic gastritis, peptic ulcers, and gastric cancer. Two major virulence factors of H. pylori have been described: the pathogenicity island cag (cag PAI) and the vacuolating cytotoxin gene (vacA). Virtually all strains have a copy of vacA, but its genotype varies. The cag PAI is a region of 32 genes in which the insertion of IS605 elements in its middle region has been associated with partial or total deletions of it that have generated strains with varying virulence. Accordingly, the aim of this work was to determine the cag PAI integrity, vacA genotype and IS605 status in groups of isolates from Mexican patients with non-peptic ulcers (NPU), non-bleeding peptic ulcers (NBPU), and bleeding peptic ulcers (BPU). Methods: The cag PAI integrity was performed by detection of eleven targeted genes along this locus using dot blot hybridization and PCR assays. The vacA allelic, cag PAI genotype 1 and IS605 status were determined by PCR analysis. Results: Groups of 16-17 isolates (n = 50) from two patients with NPU, NBPU, and BPU, respectively, were studied. 90% (45/50) of the isolates harbored a complete cag PAI. Three BPU isolates lacked the cag PAI, and two of the NBPU had an incomplete cag PAI: the first isolate was negative for three of its genes, including deletion of the cagA gene, whereas the second did not have the cagM gene. Most of the strains (76%) had the vacA s1b/m1 genotype; meanwhile the IS605 was not present within the cag PAI of any strain but was detected elsewhere in the genome of 8% (4/50). Conclusion: The patients had highly virulent strains since the most of them possessed a complete cag PAI and had a vacA s1b/m1 genotype. All the isolates presented the cag PAI without any IS605 insertion (genotype 1). Combined vacA genotypes showed that 1 NPU, 2 NBPU, and 1 BPU patients (66.6%) had a mixed infection; coexistence of H. pylori strains with different cag PAI status was observed in 1 NBPU and 2 BPU (50%) of the patients, but only two of these patients (NBPU and BPU) had different vacA genotypes.

1 January 2020 in Journal of Cancer
Verified
Journal Article
Open access
SMStephanie Euridice Morales-Guerrero
Stephanie Euridice Morales-Guerrero
CRClaudia Ivette Rivas-Ortiz
Claudia Ivette Rivas-Ortiz
SLSergio Ponce de León-Rosales
Sergio Ponce de León-Rosales
AGArmando Gamboa-Domínguez
Armando Gamboa-Domínguez
CRClaudia Rangel-Escareño
Claudia Rangel-Escareño
YVYolanda López- Vidal
Yolanda López- Vidal
Helicobacter pylori is associated with the development of several lesions in the human stomach. This chronic infection produces gastritis, which can progress to intestinal metaplasia and gastric cancer. To date, there is very little information regarding gene-expression in the different phases of progression caused by chronic H. pylori infection. In this study, we performed a genome-wide gene-expression analysis in gastric biopsies of patients chronically infected with H. pylori, using the potential of high-throughput technologies that have not been fully exploited in this area. Here we illustrate the potential correlation of H. pylori infection with the gene expression changes in follicular gastritis, chronic gastritis and intestinal metaplasia. We also suggest its potential as biomarkers of each condition. An exploratory set of 21 biopsies from patients with follicular gastritis, chronic gastritis, and intestinal metaplasia were analyzed by gene-expression microarrays in order to identify the biological processes altered in each lesion. The microarray data was corroborated by real-time PCR, while 79 Formalin-Fixed Paraffin-Embeded samples were analyzed by immunohistochemistry. Follicular gastritis exhibited significant enrichment in genes associated with glutamate signaling, while chronic gastritis showed a down-regulation in metallothionein 1 and 2 and in oxidative phosphorylation-related genes, which could be associated with the chronic infecton of H. pylori. Intestinal metaplasia exhibited an over-expression of gastrointestinal stem cell markers, such as LGR5 and PROM1, as well as messenger RNA and nucleic acid metabolism-related genes. The gene-expression patterns found in this study provide new comparative information about chronic gastritis, follicular gastritis and intestinal metaplasia that may play an important role in the development of gastric cancer.

13 November 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
SMSanta Mejia
Santa Mejia
JSJorge Soria-Bustos
Jorge Soria-Bustos
FCFernando Chimal
Fernando Chimal
GHGabriela Hernández
Gabriela Hernández
Roberto Rosales-ReyesRoberto Rosales-Reyes
Roberto Rosales-Reyes
MAMiguel A. Ares
Miguel A. Ares
The nucleoid-associated protein Fis functions as a global regulator that influences various cellular processes in Gram-negative bacteria. In this study, we examined the role of Fis in the transcriptional regulation of type 3 fimbriae in Klebsiella pneumoniae, a notable opportunistic pathogen associated with hospital-acquired infections. Our transcriptional analyses revealed that deleting the fis gene caused a significant upregulation of mrkA and mrkH, the genes responsible for the structure and regulation of type 3 fimbriae, respectively. Additionally, phenotypic assays demonstrated that the Δfis mutant exhibited enhanced biofilm formation and greater adherence to A549 lung epithelial cells compared to the wild-type strain. These effects were restored to wild-type levels in the cis-complemented strain. Electrophoretic mobility shift assays confirmed that Fis directly binds to the regulatory regions upstream of both mrkA and mrkH, indicating that repression occurs through direct interaction with the promoter. In summary, our findings show that Fis acts as a transcriptional repressor of mrkA and mrkH, thereby negatively regulating the expression of type 3 fimbriae, biofilm formation, and adherence. This study highlights Fis as a direct regulator of fimbrial expression and biofilm development in K. pneumoniae, deepening our understanding of its virulence regulatory network.